Model Medicines, Inc. — Form D
Model Medicines, Inc. of San Deigo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-07. The offering totals $2.0M, of which $950K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-07
- Form: D
- Accession: 0001892786-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.0M
- Amount sold: $950K
- Remaining: $1.1M
- Investors: 10
- Date of first sale: 2023-12-21
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-504558
Issuer
- Name: Model Medicines, Inc.
- CIK: 0001892786
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 5120 Shoreham Place, San Deigo, CA, 92122
- Phone: 619-289-7356
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Daniel Haders | Director | San Deigo, CA |
| Daniel Haders | Executive Officer | San Deigo, CA |
| Marlon Evans | Director | Palo Alto, CA |
| Marlon Evans | Executive Officer | Palo Alto, CA |
| Kip Quackenbush | Director | La Jolla, CA |
| Kip Quackenbush | Executive Officer | La Jolla, CA |
Other filings by this issuer (3)
More